Ligand Pharmaceuticals (LGND) Inventory Average (2011 - 2026)

Ligand Pharmaceuticals (LGND) has 16 years of Inventory Average data on file, last reported at $11.2 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average fell 22.06% year-over-year to $11.2 million; the trailing twelve-month figure through Mar 2026 stood at $11.2 million (down 22.06% YoY), and the FY2025 full-year result was $11.6 million, down 38.98% from the prior year.
• Inventory Average advanced to $11.2 million in Q1 2026, from $10.5 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $26.5 million in Q1 2022 to a low of $10.5 million in Q4 2025.
• A 5-year average of $18.7 million and a median of $17.8 million in 2022 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average slumped 48.42% in 2023 and soared 65.93% in 2024, its largest moves.
• Tracing LGND's Inventory Average over 5 years: stood at $17.8 million in 2022, then soared by 38.58% to $24.7 million in 2023, then slumped by 37.49% to $15.4 million in 2024, then plunged by 31.85% to $10.5 million in 2025, then gained by 6.5% to $11.2 million in 2026.
• Business Quant data shows LGND's Inventory Average at $11.2 million in Q1 2026, $10.5 million in Q4 2025, and $13.7 million in Q3 2025.